← Back to all trials
Enrolling By Invitation
NCT07898111
A Study of VAX-ID® 2200, a New Device for Intradermal Injections
Conditions: Sharps Injuries
Sex: All
Healthy volunteers: Yes
Enrollment: 15
Sponsor: Memorial Sloan Kettering Cancer Center
Location: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York
Summary
The researchers are doing this study to find out whether the VAX-ID® 2200 device is safe and easy to use for healthcare professionals who give intradermal injections.
The VAX-ID® 2200 is a small device that attaches to a standard syringe and guides the needle to the right depth in the skin. This helps make sure the injection is given correctly every time.
Eligibility Criteria
Inclusion Criteria:
* Licensed healthcare professionals (nurses, doctors, or pharmacists)
* Willing to provide informed consent and comply with study instructions and procedures.
Exclusion Criteria:
* Previous user experience with VAX-ID® 2200.
* Physical and sensory limitations affecting device handling (conditions like hand tremors, muscle weakness, vision loss/weakness, and reduced tactile sensitivity)
Source: ClinicalTrials.gov (NCT07898111). StuddyBuddy aggregates publicly available trial information.
